deoxycytidine has been researched along with tranilast in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashiguchi, K; Hiraki, M; Kai, K; Kitajima, Y; Mitsuno, M; Miyazaki, K; Nakamura, J; Noshiro, H; Ohtaka, K | 1 |
1 other study(ies) available for deoxycytidine and tranilast
Article | Year |
---|---|
Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Separation; Deoxycytidine; Drug Synergism; Flow Cytometry; Gemcitabine; Humans; In Situ Nick-End Labeling; ortho-Aminobenzoates; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases | 2010 |